Novel molecular panel for evaluating systemic inflammation and survival in therapy naïve glioma patients

Table 1 Demographic features and concentrations of molecular markers of recruited subjects

No.	Factors	Controls	IDH-mutant	IDH-wildtype
1	Sample size, (n)	(n = 45)	60	30
2	Sex, M/F	M = 30; F = 15	M = 51; F = 9	M = 25; F = 5
3	Age (yr)	25 (21-50)	35.0 (13-75)	51.5 (25-76)
4	Site	-	Frontal = 37/Non-frontal = 23	Frontal = 12/Non-frontal = 18
5	EOR	-	STR = 38; GTR = 14	STR = 30; GTR = 0
6	OS	-	28.5 (1-158)	6.5 (1-38)

Values presented as median with range. M: Male; F: Female; EOR: Extent of resection; STR: Sub-total resection; GTR: Gross total resection; OS: Overall survival; IDH: Isocitrate dehydrogenase.